PORTFOLIO NEWS eGenesis Appoints Ariel Jasie as Chief Business Officer and General Counsel Jun 11, 2019 Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of Brain Penetrant Enzyme Replacement Programs Jun 11, 2019 GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments Jun 6, 2019 Aledade and the Louisiana Physicians Accountable Care Organization Partner to Deliver High-Quality Care and Lower Costs Jun 4, 2019 GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study May 31, 2019 Aledade, California Medical Association Announce Collaboration to Help Physicians Deliver Better Care at Lower Cost May 30, 2019 GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting May 15, 2019 GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation May 13, 2019 Editas Medicine Announces First Quarter 2019 Results and Update May 7, 2019 Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV May 7, 2019 « Older Entries Next Entries » PORTFOLIO PRESS COVERAGE WIRED: The Rise of the DNA Data Storage Jun 26, 2018 GenomeWeb: New Products Posted to GenomeWeb: Thermo Fisher Scientific, Twist Bioscience, 10X Genomics, More Jun 22, 2018 Chemical & Engineering News: Synthetic biology could enable bioweapons development Jun 19, 2018 SynBioBeta: Targeted Sequencing Changes the NGS Game Jun 18, 2018 BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist Jun 6, 2018 SynBioBeta: Why the future will be written in DNA: An interview with Twist Bioscience’s Bill Peck May 15, 2018 Scientific American: Scientists Downsize Bold Plan to Make Human Genome from Scratch May 1, 2018 Retina Today: In Pursuit of an Earlier Diagnosis May 1, 2018 MedCity News: Past the hype, what can AI accomplish in healthcare? Mar 26, 2018 BBC: How DNA can be used to store computer data Mar 23, 2018 « Older Entries Next Entries »
Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of Brain Penetrant Enzyme Replacement Programs Jun 11, 2019
GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments Jun 6, 2019
Aledade and the Louisiana Physicians Accountable Care Organization Partner to Deliver High-Quality Care and Lower Costs Jun 4, 2019
GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study May 31, 2019
Aledade, California Medical Association Announce Collaboration to Help Physicians Deliver Better Care at Lower Cost May 30, 2019
GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting May 15, 2019
GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation May 13, 2019
Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV May 7, 2019
GenomeWeb: New Products Posted to GenomeWeb: Thermo Fisher Scientific, Twist Bioscience, 10X Genomics, More Jun 22, 2018
BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist Jun 6, 2018
SynBioBeta: Why the future will be written in DNA: An interview with Twist Bioscience’s Bill Peck May 15, 2018
